Nature, Published online: 11 February 2026; doi:10.1038/s41586-026-10129-y

An orthosteric CSN inhibitor gains nanomolar potency via a molecular-glue mechanism, stabilizing a CSN5–N8–inhibitor complex that confers substrate-dependent inhibition despite weak free-enzyme affinity.

From Nature via this RSS feed